Base covered, total thin, NAV slipping. A 12.34% yield on the $0.31 quarterly base dividend is covered — Q2 2026 adjusted NII of $0.34 a share covers the base 110% — but the full $0.33 declared (base plus a $0.02 supplemental) takes 97% of adjusted NII, and NAV fell to $14.26 from $14.41 in the quarter on credit markdowns, with non-accruals rising to 2.8% of cost. The base holds; the cushion around it is thinning, so the House grades it a caution.
Key risk: Credit markdowns spreading — one name (Loparex) drove most of the Q2 NAV decline, but if markdowns broaden beyond single credits, NII coverage and NAV fall together.
Changes if: Adjusted NII falls below the $0.31 base, or non-accruals keep rising from 2.8% of cost. Either would turn a thinning cushion into an uncovered base.
- ✓Base coverage check: Adjusted NII of $0.34 a share in Q2 2026 against a $0.31 base dividend — 110% coverage, as the company reported.
- !Total-payout check: Dividends declared totaled $0.33 a share in Q2 (base $0.31 plus supplemental $0.02) — 97% of adjusted NII. Only the base is the promise; the supplemental absorbs the volatility.
- !Credit check: NAV per share fell to $14.26 from $14.41 in the quarter, on $110.4 million of net realized and unrealized losses, and non-accruals rose to 2.8% of portfolio cost (0.8% at fair value).
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.